nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4D—esophageal cancer	0.822	1	CbGaD
Flavoxate—PDE8B—larynx—esophageal cancer	0.0197	0.318	CbGeAlD
Flavoxate—PDE8B—neck—esophageal cancer	0.00521	0.0844	CbGeAlD
Flavoxate—PDE8B—bronchus—esophageal cancer	0.00349	0.0565	CbGeAlD
Flavoxate—PDE8A—bronchus—esophageal cancer	0.00314	0.0509	CbGeAlD
Flavoxate—PDE8A—smooth muscle tissue—esophageal cancer	0.00307	0.0498	CbGeAlD
Flavoxate—PDE7B—lung—esophageal cancer	0.00283	0.0458	CbGeAlD
Flavoxate—PDE8A—trachea—esophageal cancer	0.00282	0.0457	CbGeAlD
Flavoxate—PDE8B—lung—esophageal cancer	0.00225	0.0365	CbGeAlD
Flavoxate—PDE8A—lung—esophageal cancer	0.00203	0.0328	CbGeAlD
Flavoxate—PDE7B—lymph node—esophageal cancer	0.00193	0.0313	CbGeAlD
Flavoxate—Antrafenine—PTGS1—esophageal cancer	0.00185	0.427	CrCbGaD
Flavoxate—PDE4D—lung—esophageal cancer	0.00184	0.0297	CbGeAlD
Flavoxate—PDE4A—lung—esophageal cancer	0.00162	0.0263	CbGeAlD
Flavoxate—PDE8B—lymph node—esophageal cancer	0.00154	0.0249	CbGeAlD
Flavoxate—PDE4B—bronchus—esophageal cancer	0.0015	0.0243	CbGeAlD
Flavoxate—Raloxifene—CYP19A1—esophageal cancer	0.00143	0.329	CrCbGaD
Flavoxate—PDE8A—lymph node—esophageal cancer	0.00139	0.0224	CbGeAlD
Flavoxate—PDE4B—trachea—esophageal cancer	0.00135	0.0218	CbGeAlD
Flavoxate—PDE4D—lymph node—esophageal cancer	0.00126	0.0203	CbGeAlD
Flavoxate—CHRM1—trachea—esophageal cancer	0.00122	0.0197	CbGeAlD
Flavoxate—PDE4A—lymph node—esophageal cancer	0.00111	0.018	CbGeAlD
Flavoxate—Antrafenine—PTGS2—esophageal cancer	0.00106	0.244	CrCbGaD
Flavoxate—PDE4B—lung—esophageal cancer	0.000969	0.0157	CbGeAlD
Flavoxate—CHRM1—lung—esophageal cancer	0.000876	0.0142	CbGeAlD
Flavoxate—PDE4B—lymph node—esophageal cancer	0.000663	0.0107	CbGeAlD
Flavoxate—PDE4A—Signaling Pathways—SST—esophageal cancer	4e-05	0.000356	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KMT2D—esophageal cancer	3.99e-05	0.000355	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—EP300—esophageal cancer	3.96e-05	0.000353	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KMT2D—esophageal cancer	3.94e-05	0.000351	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOS3—esophageal cancer	3.93e-05	0.000349	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOS3—esophageal cancer	3.93e-05	0.000349	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PDE4D—esophageal cancer	3.91e-05	0.000348	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CREBBP—esophageal cancer	3.91e-05	0.000348	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GHRL—esophageal cancer	3.9e-05	0.000347	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH3—esophageal cancer	3.9e-05	0.000347	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKAP13—esophageal cancer	3.88e-05	0.000345	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PDE4D—esophageal cancer	3.86e-05	0.000343	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—esophageal cancer	3.84e-05	0.000342	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FBXW7—esophageal cancer	3.83e-05	0.000341	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKAP13—esophageal cancer	3.83e-05	0.000341	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PSME2—esophageal cancer	3.82e-05	0.00034	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PSME1—esophageal cancer	3.82e-05	0.00034	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ANXA1—esophageal cancer	3.8e-05	0.000339	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFBR2—esophageal cancer	3.74e-05	0.000333	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—PIK3CA—esophageal cancer	3.74e-05	0.000333	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—PIK3CA—esophageal cancer	3.74e-05	0.000333	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNG7—esophageal cancer	3.72e-05	0.000331	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SST—esophageal cancer	3.7e-05	0.000329	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH2—esophageal cancer	3.67e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—ERBB2—esophageal cancer	3.67e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—ERBB2—esophageal cancer	3.67e-05	0.000327	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNG7—esophageal cancer	3.67e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—PIK3CA—esophageal cancer	3.67e-05	0.000327	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CREBBP—esophageal cancer	3.63e-05	0.000323	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH3—esophageal cancer	3.61e-05	0.000321	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GHRL—esophageal cancer	3.61e-05	0.000321	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—esophageal cancer	3.57e-05	0.000318	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADCYAP1—esophageal cancer	3.56e-05	0.000317	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PDE4D—esophageal cancer	3.55e-05	0.000316	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	3.55e-05	0.000316	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FBXW7—esophageal cancer	3.55e-05	0.000316	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SMAD4—esophageal cancer	3.54e-05	0.000315	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADCYAP1—esophageal cancer	3.51e-05	0.000313	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PDE4D—esophageal cancer	3.5e-05	0.000312	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	3.5e-05	0.000312	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOS3—esophageal cancer	3.5e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH2—esophageal cancer	3.5e-05	0.000311	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—PIK3CA—esophageal cancer	3.41e-05	0.000304	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNG7—esophageal cancer	3.38e-05	0.0003	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	3.33e-05	0.000297	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—PIK3CA—esophageal cancer	3.33e-05	0.000297	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—EP300—esophageal cancer	3.28e-05	0.000292	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL2—esophageal cancer	3.28e-05	0.000292	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ERBB2—esophageal cancer	3.27e-05	0.000291	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFBR2—esophageal cancer	3.26e-05	0.00029	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WWOX—esophageal cancer	3.25e-05	0.00029	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOS3—esophageal cancer	3.25e-05	0.000289	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CCND1—esophageal cancer	3.24e-05	0.000289	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CCND1—esophageal cancer	3.24e-05	0.000289	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH2—esophageal cancer	3.23e-05	0.000288	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	3.23e-05	0.000288	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WWOX—esophageal cancer	3.21e-05	0.000286	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CDKN1A—esophageal cancer	3.14e-05	0.000279	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CDKN1A—esophageal cancer	3.14e-05	0.000279	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFBR2—esophageal cancer	3.1e-05	0.000276	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—PIK3CA—esophageal cancer	3.1e-05	0.000276	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FKBP1A—esophageal cancer	3.1e-05	0.000275	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SMAD4—esophageal cancer	3.08e-05	0.000274	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	3.08e-05	0.000274	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	3.06e-05	0.000272	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	3.05e-05	0.000271	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ERBB2—esophageal cancer	3.04e-05	0.000271	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	3.04e-05	0.000271	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WIF1—esophageal cancer	3.03e-05	0.000269	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	3.01e-05	0.000268	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WIF1—esophageal cancer	2.99e-05	0.000266	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EP300—esophageal cancer	2.99e-05	0.000266	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EP300—esophageal cancer	2.99e-05	0.000266	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	2.97e-05	0.000265	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—SST—esophageal cancer	2.96e-05	0.000264	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	2.94e-05	0.000261	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SMAD4—esophageal cancer	2.94e-05	0.000261	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—SST—esophageal cancer	2.92e-05	0.00026	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HIF1A—esophageal cancer	2.9e-05	0.000258	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CCND1—esophageal cancer	2.89e-05	0.000257	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	2.89e-05	0.000257	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFBR2—esophageal cancer	2.87e-05	0.000255	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	2.85e-05	0.000254	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CDKN1A—esophageal cancer	2.8e-05	0.000249	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	2.79e-05	0.000248	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KDR—esophageal cancer	2.77e-05	0.000247	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	2.77e-05	0.000246	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	2.76e-05	0.000245	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	2.73e-05	0.000243	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SMAD4—esophageal cancer	2.72e-05	0.000242	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SST—esophageal cancer	2.69e-05	0.000239	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCND1—esophageal cancer	2.69e-05	0.000239	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EP300—esophageal cancer	2.66e-05	0.000237	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SST—esophageal cancer	2.66e-05	0.000236	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	2.65e-05	0.000236	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	2.62e-05	0.000233	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PFN1—esophageal cancer	2.61e-05	0.000232	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOTCH1—esophageal cancer	2.61e-05	0.000232	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—esophageal cancer	2.6e-05	0.000232	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—esophageal cancer	2.6e-05	0.000232	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CDKN1A—esophageal cancer	2.6e-05	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	2.59e-05	0.00023	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PFN1—esophageal cancer	2.58e-05	0.000229	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	2.57e-05	0.000229	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—esophageal cancer	2.54e-05	0.000226	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—esophageal cancer	2.54e-05	0.000226	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HIF1A—esophageal cancer	2.52e-05	0.000225	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EP300—esophageal cancer	2.47e-05	0.00022	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KDR—esophageal cancer	2.41e-05	0.000215	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HIF1A—esophageal cancer	2.4e-05	0.000214	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CREBBP—esophageal cancer	2.37e-05	0.000211	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	2.35e-05	0.000209	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	2.35e-05	0.000209	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—esophageal cancer	2.33e-05	0.000207	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—esophageal cancer	2.32e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	2.32e-05	0.000206	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	2.3e-05	0.000204	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KDR—esophageal cancer	2.3e-05	0.000204	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	2.29e-05	0.000204	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH1—esophageal cancer	2.27e-05	0.000202	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—esophageal cancer	2.27e-05	0.000202	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	2.26e-05	0.000201	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—PIK3CA—esophageal cancer	2.22e-05	0.000198	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HIF1A—esophageal cancer	2.22e-05	0.000198	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PIK3CA—esophageal cancer	2.21e-05	0.000197	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PIK3CA—esophageal cancer	2.21e-05	0.000197	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH1—esophageal cancer	2.16e-05	0.000193	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—esophageal cancer	2.16e-05	0.000192	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—esophageal cancer	2.14e-05	0.00019	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—esophageal cancer	2.14e-05	0.00019	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KDR—esophageal cancer	2.13e-05	0.000189	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOS3—esophageal cancer	2.12e-05	0.000189	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	2.12e-05	0.000188	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—esophageal cancer	2.11e-05	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	2.1e-05	0.000187	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	2.09e-05	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	2.07e-05	0.000184	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CREBBP—esophageal cancer	2.06e-05	0.000183	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—esophageal cancer	2.03e-05	0.00018	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PIK3CA—esophageal cancer	2.02e-05	0.00018	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH1—esophageal cancer	2e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNG7—esophageal cancer	1.99e-05	0.000178	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ERBB2—esophageal cancer	1.98e-05	0.000176	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNG7—esophageal cancer	1.97e-05	0.000175	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PIK3CA—esophageal cancer	1.97e-05	0.000175	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CREBBP—esophageal cancer	1.96e-05	0.000175	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PIK3CA—esophageal cancer	1.94e-05	0.000172	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—esophageal cancer	1.93e-05	0.000172	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—esophageal cancer	1.9e-05	0.000169	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—XIAP—esophageal cancer	1.87e-05	0.000166	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOS3—esophageal cancer	1.85e-05	0.000164	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—XIAP—esophageal cancer	1.84e-05	0.000164	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CA—esophageal cancer	1.84e-05	0.000164	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CA—esophageal cancer	1.83e-05	0.000163	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CREBBP—esophageal cancer	1.82e-05	0.000162	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—esophageal cancer	1.78e-05	0.000159	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—esophageal cancer	1.77e-05	0.000158	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	1.77e-05	0.000157	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CA—esophageal cancer	1.76e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	1.76e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOS3—esophageal cancer	1.76e-05	0.000156	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCND1—esophageal cancer	1.75e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	1.74e-05	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	1.73e-05	0.000154	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB2—esophageal cancer	1.73e-05	0.000154	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—esophageal cancer	1.7e-05	0.000152	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN1A—esophageal cancer	1.69e-05	0.000151	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—esophageal cancer	1.67e-05	0.000149	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB2—esophageal cancer	1.64e-05	0.000146	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSME1—esophageal cancer	1.64e-05	0.000146	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSME2—esophageal cancer	1.64e-05	0.000146	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	1.63e-05	0.000145	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—esophageal cancer	1.63e-05	0.000145	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSME2—esophageal cancer	1.62e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSME1—esophageal cancer	1.62e-05	0.000144	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	1.61e-05	0.000144	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EP300—esophageal cancer	1.61e-05	0.000143	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SST—esophageal cancer	1.59e-05	0.000141	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SST—esophageal cancer	1.57e-05	0.00014	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GHRL—esophageal cancer	1.55e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	1.55e-05	0.000138	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—esophageal cancer	1.55e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	1.53e-05	0.000136	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GHRL—esophageal cancer	1.53e-05	0.000136	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—esophageal cancer	1.52e-05	0.000136	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	1.52e-05	0.000136	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB2—esophageal cancer	1.52e-05	0.000135	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	1.5e-05	0.000134	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN1A—esophageal cancer	1.48e-05	0.000131	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—esophageal cancer	1.45e-05	0.000129	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—esophageal cancer	1.41e-05	0.000125	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1A—esophageal cancer	1.4e-05	0.000125	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EP300—esophageal cancer	1.4e-05	0.000125	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	1.39e-05	0.000124	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—esophageal cancer	1.37e-05	0.000122	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	1.37e-05	0.000122	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—esophageal cancer	1.34e-05	0.00012	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EP300—esophageal cancer	1.34e-05	0.000119	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1A—esophageal cancer	1.3e-05	0.000116	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EP300—esophageal cancer	1.24e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	1.23e-05	0.00011	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—esophageal cancer	1.22e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	1.22e-05	0.000108	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—esophageal cancer	1.2e-05	0.000106	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—esophageal cancer	1.19e-05	0.000106	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	1.17e-05	0.000104	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—esophageal cancer	1.16e-05	0.000104	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—esophageal cancer	1.15e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	1.15e-05	0.000102	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—esophageal cancer	1.14e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—esophageal cancer	1.08e-05	9.59e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—esophageal cancer	1.05e-05	9.38e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—esophageal cancer	1.04e-05	9.24e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—esophageal cancer	1e-05	8.94e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—esophageal cancer	9.88e-06	8.8e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—esophageal cancer	9.56e-06	8.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	9.54e-06	8.49e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	9.42e-06	8.38e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—esophageal cancer	9.14e-06	8.14e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—esophageal cancer	9.13e-06	8.12e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—esophageal cancer	9.01e-06	8.02e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—esophageal cancer	8.85e-06	7.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	8.6e-06	7.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	8.49e-06	7.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	7.8e-06	6.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	7.7e-06	6.85e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	7.66e-06	6.82e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	7.56e-06	6.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	7.32e-06	6.52e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	7.23e-06	6.43e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—esophageal cancer	6.98e-06	6.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—esophageal cancer	6.89e-06	6.13e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	6.65e-06	5.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	6.56e-06	5.84e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	6.53e-06	5.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	6.44e-06	5.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—esophageal cancer	5.77e-06	5.13e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—esophageal cancer	5.69e-06	5.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	5.58e-06	4.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	5.51e-06	4.9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EP300—esophageal cancer	5.31e-06	4.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EP300—esophageal cancer	5.24e-06	4.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—esophageal cancer	4.63e-06	4.12e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—esophageal cancer	4.57e-06	4.06e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—esophageal cancer	4.53e-06	4.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—esophageal cancer	4.47e-06	3.98e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	3.93e-06	3.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	3.88e-06	3.45e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—esophageal cancer	3.8e-06	3.38e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—esophageal cancer	3.75e-06	3.34e-05	CbGpPWpGaD
